{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:43:03Z","timestamp":1794469383097,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016913","name":"MSDAVENIR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["NCT02157662"],"award-info":[{"award-number":["NCT02157662"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.atherosclerosis.2025.120410","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T02:38:41Z","timestamp":1749782321000},"page":"120410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques"],"prefix":"10.1016","volume":"407","author":[{"given":"Marco","family":"Magnoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Andreini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Maseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Pietro","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4973-2205","authenticated-orcid":false,"given":"Giuseppina","family":"Caligiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10279","key":"10.1016\/j.atherosclerosis.2025.120410_bib1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(21)00272-5","article-title":"Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data","volume":"397","author":"Figtree","year":"2021","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2025.120410_bib2","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120410_bib3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"35","key":"10.1016\/j.atherosclerosis.2025.120410_bib4","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1093\/eurheartj\/ehad453","article-title":"Colchicine for cardiovascular prevention: the dawn of a new era has finally come","volume":"44","author":"Bonaventura","year":"2023","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120410_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/cvr\/cvz132","article-title":"Mechanotransduction, immunoregulation, and metabolic functions of CD31 in cardiovascular pathophysiology","volume":"115","author":"Caligiuri","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2025.120410_bib6","doi-asserted-by":"crossref","first-page":"17183","DOI":"10.1016\/S0021-9258(17)32538-3","article-title":"Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form","volume":"269","author":"Goldberger","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120410_bib7","series-title":"Detection of platelet-derived shed CD31 patent US9534036B2","author":"Caligiuri","year":"2013"},{"key":"10.1016\/j.atherosclerosis.2025.120410_bib8","series-title":"Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways patent US2011229981A1","author":"Caligiuri","year":"2011"},{"key":"10.1016\/j.atherosclerosis.2025.120410_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2015.11.017","article-title":"Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIRE) study","volume":"173","author":"Magnoni","year":"2016","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120410_bib10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jcmg.2012.03.009","article-title":"A long-term prognostic value of coronary CT angiography in suspected coronary artery disease","volume":"5","author":"Andreini","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120410_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"Min","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120410_bib12","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jcmg.2019.06.019","article-title":"Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events","volume":"13","author":"Andreini","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120410_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcct.2020.03.005","article-title":"Association of high-risk coronary atherosclerosis at CCTA with clinical and circulating biomarkers: insight from CAPIRE study","volume":"15","author":"Conte","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.atherosclerosis.2025.120410_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis (\u2217)","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120410_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.00-0372com","article-title":"PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics","volume":"15","author":"Ilan","year":"2001","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120410_bib16","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1538-7836.2004.00954.x","article-title":"Cleavage of platelet endothelial cell adhesion molecule-1 (PECAM-1) in platelets exposed to high shear stress","volume":"2","author":"Naganuma","year":"2004","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120410_bib17","doi-asserted-by":"crossref","DOI":"10.15212\/CVIA.2024.0032","article-title":"Causal relationship between PECAM-1 level and cardiovascular diseases: a mendelian randomization study","volume":"9","author":"Sun","year":"2024","journal-title":"CVIA"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120410_bib18","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2016.02.002","article-title":"Usefulness of high-sensitivity cardiac troponin T for the identification of outlier patients with diffuse coronary atherosclerosis and low-risk factors","volume":"117","author":"Magnoni","year":"2016","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120410_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040669","article-title":"Osteopontin as candidate biomarker of coronary disease despite low cardiovascular risk: insights from CAPIRE study","volume":"11","author":"Carbone","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.atherosclerosis.2025.120410_bib20","article-title":"Differential proteomics of cardiovascular risk and coronary artery disease in humans","volume":"8","author":"Ferrannini","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120410_bib21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2337\/dc19-1902","article-title":"Coronary artery disease and type 2 diabetes: a proteomic study","volume":"43","author":"Ferrannini","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2025.120410_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ahj.2015.11.017","article-title":"Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: protective and novel Individual Risk factors Evaluation (CAPIRE) study","volume":"173","author":"Magnoni","year":"2016","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120410_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12020123","article-title":"Why do high-risk patients develop or not develop coronary artery disease? Metabolic insights from the CAPIRE study","volume":"12","author":"Deidda","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120410_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/bbrc.1999.1018","article-title":"CD31 (PECAM-1) exists as a dimer and is heavily N-glycosylated","volume":"261","author":"Newton","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"50","key":"10.1016\/j.atherosclerosis.2025.120410_bib25","doi-asserted-by":"crossref","first-page":"26216","DOI":"10.1074\/jbc.M116.756502","article-title":"The role of sialylated glycans in human platelet endothelial cell adhesion molecule 1 (PECAM-1)-mediated trans homophilic interactions and endothelial cell barrier function","volume":"291","author":"Lertkiatmongkol","year":"2016","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120410_bib26","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.4049\/jimmunol.0902219","article-title":"TCR stimulation drives cleavage and shedding of the ITIM receptor CD31","volume":"184","author":"Fornasa","year":"2010","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120410_bib27","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120410_bib28","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120410_bib29","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"108","author":"Baldus","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.120410_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","article-title":"Pentraxin 3 in cardiovascular disease","volume":"10","author":"Ristagno","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120410_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025013085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025013085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:08:34Z","timestamp":1778944114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025013085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"alternative-id":["S0021915025013085"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120410","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120410"}}